4 0 6 VOLUME 13 NUMBER 4 APRIL 2012 nature immunology A r t i c l e s cells resulted in the induction of Cxcr5 (which encodes the chemokine receptor CXCR5) and a subset of T FH genes. Mechanistically, altering the ratio of Bcl-6 to T-bet in T H 1 cells allowed Bcl-6 to repress its direct target gene Prdm1 (which encodes the transcriptional repressor Blimp-1). Notably, Blimp-1 was directly responsible for the repression of a subset of T FH signature genes in effector T H 1 cells. Therefore, the Bcl-6dependent repression of Blimp-1 'translated' the repressive activity of Bcl-6 into induction potential for a subset of T FH genes.
RESULTS
T-bet interacts with the Bcl-6 DNA-binding domain We found that T-bet physically interacted with Bcl-6 in T H 1 cells 24 (Fig. 1a) , an interaction that targets T-bet-Bcl-6 complexes to a subset of T-bet DNA-binding elements 24 . That finding raised the question of why T-bet-Bcl-6 complexes are 'preferentially' targeted to the DNA-binding elements of T-bet rather than those of Bcl-6. To begin to address this question, we used coimmunoprecipitation analysis to define the domains in Bcl-6 and T-bet required for their interaction. A Bcl-6 truncation construct with deletion of its entire carboxy-terminal zinc-finger domain did not associate with T-bet 24 (Fig. 1b and Supplementary Fig. 1a ). This domain contains six zinc fingers, of which the four most carboxyterminal zinc fingers are required for DNA binding 26 . More detailed Bcl-6 truncation analysis demonstrated that the zinc fingers known to mediate the DNA-binding activity of Bcl-6 were also those required for its interaction with T-bet ( Fig. 1b) .
Next we located the domain in T-bet required for its association with Bcl-6. T-bet is composed of a central T-box DNA-binding domain as well as amino-and carboxy-terminal domains that mediate proteinprotein interactions and transactivation events (Supplementary Fig. 1a) . Truncation of the amino-terminal domain of T-bet did not impair its ability to interact with Bcl-6, whereas a T-bet C-terminal truncation construct did not associate with Bcl-6 in the coimmunoprecipitation analysis ( Fig. 1c) . Collectively, these data suggested that the interaction between T-bet and Bcl-6 has the potential to inhibit the DNA-binding activity of Bcl-6 while leaving the T-box DNA-binding domain exposed.
A T-bet-Bcl-6 complex inhibits Bcl-6-dependent repression To begin to address whether the interaction between T-bet and Bcl-6 interferes with the DNA-binding activity of Bcl-6, we transfected cells with luciferase reporter constructs containing either the Prdm1 promoter alone or sequence encoding multimers of Bcl-6 DNA-binding elements upstream of the minimal SV40 promoter (3x-Bcl-6 promoter reporter). The 3x-Bcl-6 promoter reporter construct represents a simplified scenario in which the repression of a minimal promoter is solely dependent on Bcl-6 DNA-binding elements. The Prdm1 promoter reporter represents a direct Bcl-6 target gene in the context of a physiologically relevant (and thus more complex) promoter setting. We used EL4 mouse lymphoma T cells for these experiments because they endogenously express Bcl-6 but do not express T-bet 15, 24 . As a control, we first confirmed that Bcl-6 repressed the activity of the 3x-Bcl-6 and Prdm1 promoter reporters ( Supplementary Fig. 1b,c) .
If the interaction between T-bet and Bcl-6 inhibits the binding of Bcl-6 to DNA, then a T-bet-Bcl-6 complex would prevent Bcl-6 from targeting to its own binding sites. In this scenario, increasing T-bet expression would enhance the formation of T-bet-Bcl-6 complexes and effectively block Bcl-6 from repressing its own target genes. To test this possibility, we assessed whether increasing T-bet expression inhibited Bcl-6 from repressing the 3x-Bcl-6 and Prdm1 promoter reporter constructs. For these experiments, we used a DNA-bindingmutant construct of T-bet to exclude the possibility that T-bet directly Figure 1 A T-bet-Bcl-6 complex inhibits Bcl-6-dependent repression. (a) Coimmunoprecipitation (IP) of endogenously expressed proteins from wild-type (WT) T H 1 cells with control antibody (to the V5 epitope tag) or anti-Bcl-6, followed by immunoblot analysis (IB) with anti-T-bet (α-T-bet). Input, immunoblot analysis without immunoprecipitation. (b,c) Coimmunoprecipitation of proteins from EL4 T cells transfected with an untagged T-bet expression construct in combination with V5tagged wild-type Bcl-6 or Bcl-6 with deletion of zinc fingers known to mediate its DNA-binding activity (Bcl-6∆ZF DB ) or its entire carboxyterminal zinc-finger domain (Bcl-6∆ZF; b) or with untagged Bcl-6 in combination with wildtype V5-tagged T-bet or T-bet with truncation of the amino-terminal domain (T-bet∆N) or carboxy-terminal region (T-bet∆C; c), followed by immunoprecipitation of proteins from lysates with anti-T-bet (b) or anti-Bcl-6 (c) and immunoblot analysis with anti-V5. (d,e) Luciferase activity in EL4 T cells cotransfected with a 3x-Bcl-6 promoter (d) or Prdm1 promoter (e) luciferase reporter and either empty expression plasmid (control (Ctrl)) or increasing concentrations of expression plasmid for a T-bet DNA-binding mutant (T-bet(DBmut)) or T-bet with truncation of the carboxy-terminal region (T-bet∆C); results are normalized to a renilla luciferase control and are presented in relative light units (RLU) relative to activity in the control condition. (f) Luciferase activity in EL4 T cells cotransfected with the Prdm1 promoter luciferase reporter and empty vector or vector for the T-bet DNA-binding mutant alone or in combination with Bcl-6 (presented as in d,e). (g,h) Quantitative RT-PCR analysis of RNA isolated from wild-type or Tbx21 -/primary CD4 + T cells polarized in T H 1 conditions; expression was normalized to expression of the control gene Rps18 (encoding ribosomal protein S18) and results are presented relative to those of wildtype T H 1 cells (g) or Tbx21 -/cells (h). Data are representative of at least three (a-f,h) or five (g) independent experiments (mean and s.e.m. in d-h). Notably, overexpression of the T-bet DNA-binding-mutant construct alone substantially enhanced 3x-Bcl-6 and Prdm1 promoter reporter activity but did not activate a control reporter containing the promoter of Ifng (which encodes the T H 1 cytokine interferon-γ; Fig. 1d ,e and Supplementary Fig. 1d,e ). We also did the promoter-reporter experiments with the T-bet C-terminal-truncation construct that did not interact with Bcl-6 ( Fig. 1c) . This construct did not inhibit Bcl-6dependent repression (Fig. 1d,e and Supplementary Fig. 1d ), which suggested that the interaction between T-bet and Bcl-6 was required for the ability of T-bet to alleviate the Bcl-6-dependent repression of the 3x-Bcl-6 and Prdm1 promoter reporters. We next hypothesized that the relative expression of T-bet and Bcl-6 defines the functional activity of Bcl-6 when both are expressed in the same cell. That is, in the presence of excess T-bet, formation of the T-bet-Bcl-6 complex inhibited most Bcl-6 from localizing to its own DNA-binding elements ( Fig. 1d,e ). However, an increase in the abundance of Bcl-6 in the presence of constant T-bet expression would allow excess Bcl-6 to interact with its own DNA-binding elements. To test this hypothesis, we overexpressed Bcl-6 in conjunction with the T-bet DNA-binding mutant and examined the functional consequences on Bcl-6-dependent repression. Bcl-6 overexpression restored repression of the 3x-Bcl-6 and Prdm1 promoter reporters despite the presence of the T-bet DNA-binding mutant ( Fig. 1f and Supplementary  Fig. 1f,g) . These data suggested that the ratio of T-bet to Bcl-6 determines whether Bcl-6 can repress its direct target genes.
Expression of T FH signature genes in T-bet-deficient cells
Although the T-bet-Bcl-6 complex is functionally important for repressing a subset of T-bet target genes, it remains unclear whether the T-bet-Bcl-6 complex prevents Bcl-6 from repressing its direct target genes in T H 1 cells 24 . To begin to explore this question, we examined endogenous Prdm1 expression in primary CD4 + T cells isolated from wild-type or T-bet-deficient (Tbx21 -/-) mice and then polarized in T H 1 conditions. In this experimental setting, both wild-type and Tbx21 -/cells have constant, low Bcl-6 expression 24 , but because T-bet is not present to form a complex with Bcl-6 in the Tbx21 -/cells, this may allow 'free' Bcl-6 to repress its direct target genes. Consistent with that hypothesis, Prdm1 expression was lower in Tbx21 -/-T H 1 cells than in wild-type T H 1 cells ( Fig. 1g) .
We next wanted to determine whether changes in the functional activity of Bcl-6 in the T-bet-deficient setting would induce a T FH cell-like gene-expression profile. A subset of T FH signature genes 1, 27 , including Cxcr5, Il6ra (which encodes the IL-6 receptor α-chain), Btla (which encodes the inhibitory receptor CD272) and Tnfsf8 (which encodes the ligand for the immunoregulatory receptor CD30), had higher expression in Tbx21 -/-T H 1-polarized cells than in wild-type T H 1-polarized cells ( Fig. 1h) . To further explore those results, we also knocked down Tbx21 in wild-type T H 1-polarized cells through the use of small interfering RNA (siRNA). In this experimental strategy, CD4 + T cells commit to the T H 1 pathway in the presence of T-bet, which allowed us to examine the functional consequence of lower T-bet expression in a natural T H 1 setting. Similar to the data obtained with T-bet-deficient cells, knockdown of Tbx21 in wild-type T H 1 cells resulted in the induction of a subset of T FH signature genes ( Supplementary Fig. 2) . Collectively, these experiments suggested that the interaction between T-bet and Bcl-6 functionally regulated the activity of both T-bet and Bcl-6 in T H 1 cells 24 ( Fig. 1 and Supplementary Figs. 1 and 2) .
IL-2 signaling inhibits Bcl-6 expression in T H 1 cells
The mechanistic findings presented thus far suggested that there may be flexibility between the T H 1 and T FH gene programs if environmental signaling events regulate Bcl-6 expression in T H 1 cells. Therefore, we wanted to determine whether signaling pathways in developing T H 1 cells modulate Bcl-6 expression. Published research has suggested that IL-2 signaling regulates Bcl-6 expression in some circumstances. Specifically, Bcl-6 is repressed when CD8 + T cells are exposed to high concentrations of IL-2, whereas Bcl-6 expression is upregulated in limiting IL-2 conditions 28 . Also, an inverse correlation exists between the expression of IL-2 receptor-α (IL-2Rα) and the expression of Bcl-6 in CD4 + T FH cells 29 . Thus, we hypothesized that IL-2R signaling may regulate Bcl-6 expression in T H 1 cells.
To test that possibility, we monitored Bcl-6 expression in CD4 + T cells cultured in T H 1-polarizing conditions with a range of IL-2 concentrations. For these experiments, we stimulated CD4 + T cells for 3 d with plate-bound antibody to CD3 (anti-CD3) and anti-CD28 in the presence of T H 1-polarizing conditions and IL-2. We then split the cells and maintained them in T H 1-polarizing conditions in the presence of variable concentrations of IL-2 for an additional 3 d. In developing T H 1 cells, the expression of Bcl6 transcripts and Bcl-6 protein inversely correlated with the concentration of IL-2 ( Fig. 2a,b and Supplementary Fig. 3a,b) . In contrast, T-bet had similar expression in all IL-2 conditions (Fig. 2b,c and Supplementary Fig. 3b,c) , which indicated that T H 1-polarizing conditions were dominant over IL-2 concentrations in the regulation of T-bet expression. Together these data suggested that the environmental concentration of IL-2 regulated Bcl-6 expression, but not T-bet expression, in developing T H 1 cells.
To further explore whether signaling through IL-2R inhibits Bcl-6 expression in T H 1 cells, we incubated developing T H 1 cells with blocking npg A r t i c l e s antibodies to the IL-2Rα (CD25) and IL-2Rβ (CD122) subunits of the IL-2R complex. We found that blocking both CD25 and CD122 in combination enhanced the expression of Bcl6 transcripts and Bcl-6 protein ( Fig. 2d,e ). These data were consistent with the findings from the IL-2 'titration' experiments and together provided evidence that strong IL-2R signaling inhibited Bcl-6 expression in T H 1 cells.
IL-2 signaling regulates STAT binding to the Bcl6 promoter
We next wanted to determine the mechanism by which IL-2R signaling regulates Bcl6 expression in T H 1 cells. A scan of the transcription factor-binding elements in the Bcl6 promoter identified DNA-binding sites for the STAT and Foxo families of transcription factors (Fig. 3a) , whose activities are responsive to IL-2R signaling in T cells [30] [31] [32] . STAT5 has been suggested to inhibit a subset of genes by either displacing activating STAT3 complexes or recruiting repressive chromatinmodifying complexes to the promoter 33, 34 . Therefore, we wanted to assess whether strong IL-2 signaling inhibited Bcl6 expression by enhancing the binding of STAT5 itself and/or the ratio of STAT5 to STAT3 at the Bcl6 promoter in T H 1 cells. We first confirmed that phosphorylation of STAT5 was enhanced with increasing IL-2 concentrations in T H 1 cells (Fig. 3b) . Next we used chromatin immunoprecipitation (ChIP) to assess the binding of STAT3 and STAT5 to the Bcl6 promoter in T H 1 cells cultured in a high or low concentration of IL-2 (Fig. 3c) . The ChIP experiments demonstrated that the ratio of STAT3 to STAT5 bound to the Bcl6 promoter varied with IL-2 concentration. Specifically, the binding of STAT5 to the Bcl6 promoter was greater, whereas the binding of STAT3 was lower, in T H 1 cells cultured in a high concentration of IL-2 (Fig. 3c) . Enhanced binding of STAT5 correlated with the inhibition of Bcl6 expression in T H 1 cells exposed to increasing concentrations of IL-2 ( Fig. 2a,b) . These data were consistent with a repressive role for STAT5 in the IL-2-dependent regulation of Bcl6 expression in T H 1 cells.
Foxo factors regulate Bcl6 expression in T H 1 cells
Published studies have suggested that strong IL-2R signaling inhibits the activity of Foxo transcription factors in T cells. IL-2 induces a microRNA that inhibits Foxo1 expression, and it also prevents the translocation of members of the Foxo family to the nucleus 32, 35 . Notably, there were Foxo-binding elements in the Bcl6 promoter and Foxo transcription factors were able to activate the Bcl6 promoter 36 (Fig. 3a and Supplementary Fig. 4a,b) . Therefore, we wanted to determine whether Bcl6 is a direct, IL-2-responsive target gene of Foxo transcription factors in T H 1 cells.
Consistent with published findings obtained with nonpolarized CD4 + T cells 32 , Foxo1 expression was lower in T H 1 cells cultured in a high concentration of IL-2 ( Supplementary Fig. 4c ). We next did ChIP experiments to assess the binding of Foxo1 and Foxo3a to the Bcl6 promoter in T H 1 cells maintained in a high or low concentration of IL-2 ( Fig. 3d) . Both Foxo1 and Foxo3a bound to the Bcl6 promoter when T H 1 cells were maintained in a low concentration of IL-2, which correlated with Bcl6 expression in those conditions. In contrast, binding of Foxo1 and Foxo3a to the Bcl6 promoter was substantially lower in T H 1 cells cultured in a high concentration of IL-2 ( Fig. 3d) . Collectively, these data suggested that IL-2 regulated binding of the transcriptional activators Foxo1 and Foxo3a to the Bcl6 promoter in primary T H 1 cells.
T H 1 cells can upregulate a T FH -like gene profile
We next wanted to determine whether the greater abundance of Bcl-6 in T H 1 cells altered the gene-expression profile of the cell (Fig. 4) . We first examined expression of the direct Bcl-6 target Prdm1 in T H 1 cells cultured in variable IL-2 conditions. The expression of Prdm1 transcripts and Blimp-1 protein was substantially lower in T H 1 cells maintained in a limiting concentration of IL-2 ( Figs. 2b and 4a and Supplementary Fig. 3b) . Notably, there seemed to be a threshold for the amount of Bcl-6 needed for effective repression of Blimp-1 expression. These data suggested that similar to the findings reported above (Fig. 1) , naturally increasing the ratio of Bcl-6 to T-bet above a threshold in primary T H 1 cells resulted in the functional repression of a prototypic Bcl-6 target gene. Quantitative RT-PCR analysis of the expression of Prdm1 (a), Ifng (b) or T FH cell-associated genes (c) in primary wild-type CD4 + T cells cultured continuously for 6 d in T H 1-polarizing conditions, with decreasing concentrations of IL-2 (wedges) from day 3 to day 6 (as described in Fig. 2a ; results normalized and presented as in Fig. 2a ). Data represent four independent experiments (mean and s.e.m.).
A r t i c l e s
We then assessed whether the enhanced Bcl-6 expression in T H 1 cells was sufficient to upregulate genes associated with T FH cells. Cxcr5 was induced more than 15-fold in developing T H 1 cells cultured in a low concentration of IL-2 relative to its expression in T H 1 cells maintained in a high concentration of IL-2 ( Fig. 4c) . Three other T FH cellassociated genes, Il6ra, Btla and Tnfsf8, were also upregulated in this setting (Fig. 4c) . In contrast, T H 1 cells maintained in a limiting concentration of IL-2 had lower expression of Ifng relative to its expression in T H 1 cells cultured in a high concentration of IL-2 (Fig. 4b) ; this might indicate a shift in the balance of the helper T cell program. Notably, not all T FH signature genes were induced in T H 1 cells coincident with Bcl-6 upregulation. In particular, the expression of Pdcd1 (which encodes the inhibitory receptor PD-1) and Icos (which encodes the inducible T cell costimulator ICOS) was unchanged (Supplementary Fig. 5) . These data suggested that enhanced Bcl-6 expression in T H 1 cells induced a partial T FH profile, but additional events were needed to establish the complete program.
IL-2 regulates Bcl6 expression in polarized T H 1 cells
We next wanted to determine whether fully polarized T H 1 cells retained the flexibility to modulate Bcl-6 expression in response to IL-2-signaling. To investigate this, we cultured CD4 + T cells continuously for 9 d in T H 1-polarizing conditions and either held the IL-2 concentration constant or altered it after 6 d of polarization. Bcl6 expression was induced when fully polarized T H 1 cells maintained in a high concentration of IL-2 were switched to a low concentration of IL-2 ( Fig. 5a) . Notably, the upregulation of Bcl6 in fully polarized T H 1 cells correlated with the repression of Prdm1 and the functional induction of T FH signature genes, including Cxcr5 (Fig. 5a) . In contrast, the enhanced expression of Bcl6 and T FH genes observed in a low concentration of IL-2 was substantially downregulated when T H 1polarized cells were exposed to a high concentration of IL-2 (Fig. 5b) . Collectively, these data indicated that IL-2 regulated Bcl-6 expression in both developing and fully polarized T H 1 cells.
Blimp-1 directly represses T FH genes in T H 1 cells
Bcl-6 is a transcriptional repressor and thus it is unlikely to directly activate T FH genes. Notably, the Bcl-6-dependent repression of Blimp-1 correlated with the induction of T FH signature genes in decreasing concentrations of IL-2 ( Figs. 2b and 4a,c) . Like Bcl-6, Blimp-1 is a transcriptional repressor 37, 38 . Mechanistically, if Blimp-1 directly represses T FH signature genes in effector T H 1 cells, then increasing the activity of Bcl-6, which directly represses Blimp-1, would effectively limit the 'Blimp-1 brake' in place on the T FH cell-associated genes. Therefore, Prdm1 is a good candidate as the direct Bcl-6 target gene that 'translates' Bcl-6-mediated repression into the downstream activation potential for a subset of T FH genes.
We first examined whether Blimp-1 repressed the endogenous expression of T FH signature genes in primary T H 1 cells. We transfected wild-type T H 1 cells with control or Prdm1-specific siRNA and analyzed the consequences on endogenous gene expression. Prdm1 expression was lower in T H 1 cells transfected with Prdm1-specific siRNA than in those transfected with the control siRNA ( Fig. 6a) . Consistent with a role for Blimp-1 in repressing T FH gene expression in T H 1 cells, the expression of Cxcr5, Il6ra, Btla and Tnfsf8 was substantially enhanced when Blimp-1 expression was diminished (Fig. 6a) . These data indicated that Blimp-1 functionally repressed a subset of T FH signature genes in primary effector T H 1 cells.
To start to address whether Blimp-1 has a direct role in repressing these genes, we cloned the promoters of Cxcr5, Il6ra, Btla and Tnfsf8 into luciferase reporter vectors to determine whether they were responsive to Blimp-1-mediated repression. Each of these promoters was repressed by overexpression of wild-type Blimp-1 but not by overexpression of a mutant Blimp-1 construct that lacked DNA-binding activity ( Fig. 6b and Supplementary Fig. 6a) . Thus, the promoter reporter data supported the hypothesis that Blimp-1 directly repressed the transcription of Cxcr5, Il6ra, Btla and Tnfsf8.
Blimp-1 binds to T FH cell-associated genes in T H 1 cells
If Blimp-1 directly represses IL-2-sensitive T FH signature genes in effector T H 1 cells, then binding of Blimp-1 would inversely correlate with their expression. In ChIP experiments, Blimp-1 was associated with the Cxcr5, Il6ra, Btla and Tnfsf8 promoters in T H 1 cells maintained in a high concentration of IL-2, which coincided with the repression of these genes ( Fig. 6c and Supplementary Fig. 6b) . In contrast, there was substantially less binding of Blimp-1 at the Cxcr5, Il6ra, Btla and Tnfsf8 promoters in response to a limiting concentration of IL-2 ( Fig. 6c and Supplementary Fig. 6b) . The loss of Blimp-1 binding correlated with the induction of these genes (Figs. 4c  and 6c) . Collectively, these data suggested that Blimp-1 directly bound to and repressed the IL-2-sensitive T FH signature genes in effector T H 1 cells.
Finally, we wanted to explore whether Blimp-1 is a key regulatory factor that 'translates' an increase in the ratio of Bcl-6 to T-bet in T H 1 cells into the downstream activation potential for T FH cell-associated genes. To address this, we examined the binding of Blimp-1 to the Cxcr5, Il6ra, Btla and Tnfsf8 promoters in Tbx21 -/cells. There was less binding of Blimp-1 at these promoters in Tbx21 -/-T H 1polarized cells than in wild-type T H 1-polarized cells ( Fig. 6d and  Supplementary Fig. 6c ), which coincided with higher gene expression (Fig. 1h) . Thus, Blimp-1 binding inversely correlated with npg A r t i c l e s an increase in the ratio of Bcl-6 to T-bet in T H 1 cells achieved by either natural environmental cues (Fig. 6c ) or genetic manipulation (Fig. 6d) . Therefore, the IL-2-sensitive regulation of Bcl-6 expression in T H 1 cells determined the downstream potential of a subset of T FH signature genes by controlling Blimp-1-mediated repression (Supplementary Fig. 7) .
DISCUSSION
This study has demonstrated that variable IL-2-signaling regulated Bcl-6 expression in polarized T H 1 cells. In effector T H 1 cells, a high ratio of T-bet to Bcl-6 promoted formation of the T-bet-Bcl-6 complex, which masked the Bcl-6 DNA-binding domain. As Bcl-6 expression was enhanced in T H 1 cells maintained in a low concentration of IL-2, excess Bcl-6 repressed its target gene Prdm1. Blimp-1 directly repressed a subset of T FH signature genes in effector T H 1 cells. Therefore, the Bcl-6-dependent repression of Blimp-1 was responsible for regulating the T FH gene-expression activation potential in CD4 + T cells. Collectively, these data suggested that T H 1 cells retained flexibility with a T FH cell-like gene profile by maintaining their ability to regulate the Bcl-6-Blimp-1 axis in response to IL-2.
A long-held view in the field has been that opposing helper T cell lineage-defining transcription factors are expressed in a mutually exclusive pattern, but research has questioned that simplistic paradigm. There is now increasing awareness that opposing helper T cell lineage-defining transcription factors are coexpressed in many circumstances and that their coexpression is functionally important for regulating the gene-expression profile of the cell 21, 24, [39] [40] [41] . This raises the question of how the expression and functional activities of these factors are precisely regulated during an immune response.
Our study has demonstrated that T-bet was able to dominantly control Bcl-6 activity because a T-bet-Bcl-6 complex masked the DNAbinding domain of Bcl-6 but left the DNA-binding domain of T-bet available. This effectively allowed T-bet to keep Bcl-6 in check in effector T H 1 cells. However, when Bcl-6 expression increased past the threshold of T-bet control, the balance of the cell shifted toward a T FH cell-like gene profile.
The environmental concentration of IL-2, 'translated' through the activity of STAT and Foxo transcription factors, regulated Bcl-6 expression in polarized T H 1 cells. This meant that T H 1 cells retained flexibility with a T FH cell-like gene profile because they were able to alter Bcl-6 expression in response to IL-2-signaling. A published study has found that IL-2-signaling is critical for the formation of many helper T cell lineages 42 . Our findings have added to that and suggest that IL-2-signaling can change the phenotype of polarized T H 1 cells. Notably, published research suggests that IL-2Rα expression inversely correlates with Bcl-6 expression to create a continuum of central memory T cell, T FH cell or effector T H 1 cell characteristics 29, 43 . It is possible that the expression pattern of IL-2R subunits on a CD4 + T cell will allow individual cells in a population to respond differently to the same environmental IL-2 conditions.
Our study has provided new insight into how the transcriptional repressor Bcl-6 serves to promote the expression of T FH signature genes. We found that Bcl-6-dependent repression of Prdm1 was directly responsible for regulating the transcriptional potential of some T FH signature genes. Notably, Blimp-1 is expressed in many effector helper T cell subtypes but is repressed during T FH differentiation in vivo 10, 37 . It is possible that Blimp-1 commonly represses T FH signature genes in other effector helper T cell subtypes as well.
The activation of the T FH gene program is a multistep process, with the Bcl-6-dependent removal of the 'Blimp-1 brake' representing a first step. Interactions between ICOS and its ligand in the follicle are required for the full induction of a T FH gene profile 29 . Additionally, transcriptional regulators such as Batf and c-Maf are involved in T FH differentiation 44, 45 . Further studies are needed to determine the complete series of molecular events that occur downstream of the removal of the Blimp-1-mediated repression required for full activation of T FH genes and whether polarized T H 1 cells can initiate all of these events. Of note, not all T FH signature genes, such as those encoding PD-1 and ICOS, were upregulated in a low concentration of IL-2, which indicated that distinct classes of T FH target genes exist that require either additional or completely independent events. Notably, CXCR5 hi PD-1 lo helper T cells exist outside the germinal center and represent a T FH -like cell before homing to the follicle for full differentiation 46 . We hypothesize that the CXCR5 + T H 1 cells will need to home to the follicle where the next events required for the T FH gene program occur. Overexpression of Bcl-6 alone is sufficient for complete T FH differentiation in vivo 10, 11, 13 . Therefore, because Bcl-6 expression is regulated by IL-2-signaling in T H 1 cells, given the right circumstances in vivo, T H 1 cells may retain the flexibility to adopt a T FH gene program. Fig. 1g ) of wild-type T H 1 cells transfected with control siRNA (siGFP) or Prdm1-specific siRNA (siPrdm1); results are presented relative to those of cells transfected with control siRNA. (b) Luciferase activity of EL4 T cells transfected with a Cxcr5, Il6ra, Btla or Tnfsf8 promoter luciferase reporter and empty expression vector (control) or vector for wild-type Blimp-1 or DNA-binding-mutant Blimp-1 (Blimp-1∆ZF); normalized luciferase activity is presented relative to that of cells transfected with empty expression vector. (c) ChIP analysis of wildtype T H 1-polarized cells maintained in a high or low concentration of IL-2, followed by immunoprecipitation of chromatin with anti-Blimp-1 or IgG and analysis of enrichment for Blimp-1 at various promoters; results were normalized (as in Fig. 3c ) to obtain the percentage of input ( Supplementary  Fig. 6b ) and are presented relative to those of cells maintained in a low concentration of IL-2. (d) ChIP analysis (as in c) of wild-type or Tbx21 -/-CD4 + T cells polarized in T H 1 conditions; results are presented relative to the input values for Tbx21 -/cells ( Supplementary Fig. 6c ). Data represent three independent experiments (mean and s.e.m.).
